PRESAGE BIOSCIENCES
Presage has developed a means of assessing tumor response to drugs or RNA interference agents without the limitations inherent to systemic administration. The Presage clinical surrogate approach enables drug companies to halt development projects for compounds that show no efficacy in the native tumor microenvironment. In addition, the Presage approach can identify drug targets using RNA interference without concern regarding localization or distribution of systemically administered RNAi agents. Presage technology can also be used to identify effective drug combinations in ways that more directly measure the efficacy of such combinations than otherwise possible.
PRESAGE BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-11-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.presagebio.com
Total Employee:
11+
Status:
Active
Contact:
4087333323
Email Addresses:
[email protected]
Total Funding:
32.57 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Font Awesome
Similar Organizations
CH Biomedical
CH Biomedical develops VAD technology utilizing an innovative MagLev pump design.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
LabCorp Venture Fund
LabCorp Venture Fund investment in Venture Round - Presage Biosciences
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Venture Round - Presage Biosciences
InHarv Partners
InHarv Partners investment in Venture Round - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Convertible Note - Presage Biosciences
Celgene
Celgene investment in Series D - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Series D - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Venture Round - Presage Biosciences
David Wu
David Wu investment in Seed Round - Presage Biosciences
Official Site Inspections
http://www.presagebio.com Semrush global rank: 11.36 M Semrush visits lastest month: 162
Unable to get host informations!!!
More informations about "Presage Biosciences"
About – Presage Biosciences
Nine issued US patents “A method of evaluating one or more candidate agents, wherein at least one of the one or more candidate agents is a drug, comprising: introducing the one or more candidate agents to one or more positions in a …See details»
Presage Biosciences - Crunchbase Company Profile
Organization. Presage Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Presage Biosciences develops a technology platform to improve the cancer …See details»
Team and Board – Presage Biosciences
Presage Biosciences 530 Fairview Avenue North Suite 1000 Seattle, WA 98109 [email protected]See details»
Presage Biosciences, Inc. | LinkedIn
#PresageBio is looking forward to #ASCO2024 this week, hope to see you there! 2 Like Comment Share Presage Biosciences, Inc. 1,991 followers 6mo Report this post ...See details»
Presage Biosciences - Overview, News & Similar companies
Feb 16, 2021 www.presagebio.com. Revenue <$5 Million. Industry Business Services General Business Services . Most Recent Scoops. Aug 4 2022. Left Company. Feb 17 2021. Funding. …See details»
Presage Biosciences - PitchBook
Presage Biosciences General Information Description. Developer of an oncology technology designed to improve the way drugs are developed and targeted. The company's technology delivers pharmacologically appropriate concentrations …See details»
Presage Announces FDA Study May Proceed to Evaluate Pre-GMP …
Jan 16, 2024 Presage Biosciences, a biotechnology company whose mission is to enable precision drug response evaluation in the human tumor microenvironment (TME), announced …See details»
Presage Completes First Phase 0 Clinical Study to Enable …
Nov 28, 2022 With a mission to address this fundamental issue, Presage Biosciences operates as a translational oncology research organization that is uniquely capable of providing spatial …See details»
Presage Biosciences raises $13M and inks new deal …
Mar 2, 2021 Presage CEO Richard Klinghoffer. (Presage Photo) New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck and ...See details»
Presage Biosciences Announces New Pharma Partnership to …
Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand the complexity of drug response in the tumor ...See details»
Presage Biosciences Announces New Pharma Partnership to
SEATTLE, Nov. 30, 2023 /PRNewswire/ --Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand …See details»
main – Presage Biosciences
Presage Biosciences 530 Fairview Avenue North Suite 1000 Seattle, WA 98109 [email protected]See details»
Presage Sets the Stage for Commercial Expansion with Closing of …
Mar 2, 2021 For more information, visit www.presagebio.com. Media Contact: Julie Rathbun Rathbun Communications (206) 769-9219 [email protected] SOURCE Presage Biosciences.See details»
Presage Completes First Phase 0 Clinical Study to Enable
SEATTLE, Nov. 28, 2022 /PRNewswire/ -- Presage Biosciences a biotechnology company whose mission is understanding the complexity of drug response in the tumor microenvironment, …See details»
Presage Announces Collaboration with Pure Biologics to …
SEATTLE, Feb. 6, 2023 /PRNewswire/ -- Presage Biosciences, a biotechnology company whose mission is understanding the complexity of drug response in the tumor microenvironment, …See details»
Kimberly Sottero - Presage Biosciences, Inc. | LinkedIn
Not-your-average strategy and operations leader. <br><br>Problem-Solver. Persuasive. Pragmatic. Team Player. <br><br>Energetic. Efficient. Enthusiastic. Effective ...See details»
Presage Announces FDA Study May Proceed to Evaluate Pre-GMP …
SEATTLE, Jan. 16, 2024 /PRNewswire/ -- Presage Biosciences, a biotechnology company whose mission is to enable precision drug response evaluation in the human tumor microenvironment …See details»
Presage Biosciences Announces New Pharma Partnership to …
SEATTLE, Nov. 30, 2023 /PRNewswire/ -- Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand …See details»
Presage Announces New, Multi-Project Collaboration with Takeda …
Sep 9, 2020 For more information, visit www.presagebio.com. Media Contact: Julie Rathbun Rathbun Communications (206) 769-9219 [email protected] SOURCE Presage Biosciences. …See details»